To investigate the effects of Bailing capsule as an adjuvant therapy on oxidative stress levels in follicular fluid and the oocyte quality in patients with polycystic ovary syndrome(PCOS).
A total of 98 PCOS patients admitted to Chongming hospital affiliated to Shanghai health medical university from February 2023 to January 2025 were selected and divided into the Bailing capsule group and the reference group by simple random sorting method,53 cases in each group. After attrition, the final analysis included 50 cases in the Bailing capsule group and 48 cases in the reference group. The reference group received subcutaneous injection of liraglutide on the first day of menstruation and oral administration of letrozole from D3 to D7. The Bailing capsule group received Bailing capsule as an adjuvant treatment from D5 of menstruation in addition to the treatment of the reference group. Both groups were treated for 3 menstrual cycles. The oocyte quality(number of fertilized oocytes, number of cleaved embryos, number of transplantable embryos, number of high-quality embryos), levels of oxidative stress in follicular fluid[reactive oxygen species(ROS),malondialdehyde(MDA), superoxide dismutase(SOD)], endocrine indicators[follicle-stimulating hormone(FSH),luteinizing hormone(LH), testosterone(T)], traditional Chinese medicine syndrome scores(menstrual irregularity, breast distension, dizziness and tinnitus, restlessness and discomfort) were compared between the two groups and the occurrence of adverse reactions was compared between the two groups.
After treatment, the number of fertilized oocytes,number of cleaved embryos, number of transplantable embryos, and number of high-quality embryos in the Bailing capsule group were higher than those in the reference group(P<0.05). After treatment, the levels of ROS and MDA in both groups were lower than those before treatment(P<0.05), and SOD increased(P<0.05). The improvement in the Bailing capsule group was more significant compared to the reference group(P<0.05). The levels of FSH, LH, and T in both groups were lower than those before treatment(P<0.05), and the improvement in the Bailing capsule group was more significant compared to the reference group(P<0.05). The scores of menstrual irregularity, breast distension, dizziness and tinnitus, and restlessness and discomfort in both groups were lower than those before treatment(P<0.05), and the improvement in the Bailing capsule group was more significant compared to the reference group(P<0.05). There was no significant difference in adverse reactions between the two groups(P>0.05).
Bailing capsule as an adjuvant therapy for PCOS can effectively improve the quality of oocytes in patients. Its underlying mechanism may be closely related to the improvement of the oxidative stress state of follicular fluid and the regulation of endocrine-related indicators.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |